Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit $16.9M

12th April 2017 Uncategorised 0

Opdivo lung cancer slip took a bite out of Bristol CEO’s bonus, but pay still hit $16.9M
tracy
Wed, 04/12/2017 – 10:14




More: Opdivo lung cancer slip took a bite out of Bristol CEO's bonus, but pay still hit .9M
Source: fierce